CLDX(Celldex Therapeutics, Inc.) · 财务报表

CLDX(Celldex Therapeutics, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$4.65M$2.36M$6.88M$7.02M$1.54M
毛利润$4.55M$2.26M$6.58M$6.82M$1.34M
营业利润−$71.24M−$115.23M−$154.54M−$195.08M−$287.37M
净利润−$70.51M−$112.33M−$141.43M−$157.86M−$258.76M
经营现金流−$60.91M−$103.73M−$107.29M−$157.78M−$210.94M
自由现金流−$62.16M−$105.56M−$109.11M−$159.70M−$213.66M
摊薄每股收益$-1.64$-2.40$-2.92$-2.45$-3.90

Celldex Therapeutics, Inc. CLDX